Most recent by Ruban Dhaliwal, MD, MPH
SPONSORED CONTENT
March 28, 2025
1 min read
Save
FDA grants approval to two more denosumab biosimilars
The FDA has approved two new denosumab biosimilars that are interchangeable with the reference medications Prolia and Xgeva, according to an industry press release.
SPONSORED CONTENT
May 02, 2024
1 min read
Save
FDA fast tracks PTH1 receptor agonist for treatment of hypoparathyroidism
The FDA granted fast track designation for an investigational parathyroid hormone 1 receptor agonist to treat hypoparathyroidism, according to an industry press release.
SPONSORED CONTENT
April 15, 2024
5 min read
Save
The evolving landscape of managing hypoparathyroidism
Approximately 77,000 people in the U.S. have hypoparathyroidism due to absent or subphysiological levels of parathyroid hormone.
SPONSORED CONTENT
June 13, 2022
1 min read
Save
Greater fracture risk seen with insulin vs. metformin use for adults with type 2 diabetes
ATLANTA — Adults with type 2 diabetes who were prescribed insulin had greater risks for major osteoporotic and hip fractures than those prescribed metformin, according to study data.